Skip to Main Content

Paper Details

Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate.
Clin Cancer Res
24
2020
Author NameAffiliation
Borko JovanovicUniversity of Illinois at Chicago
  • 1 - 1

Datasets

Release 1.2